VRNOF
Verano Holdings Corp. [VRNOF] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VRNOF Stock Summary
Top 10 Correlated ETFs
VRNOF
Top 10 Correlated Stocks
VRNOF
In the News
VRNOF Financial details
Company Rating
Neutral
Market Cap
1.74B
Income
-114.72M
Revenue
945.01M
Book val./share
3.59
Cash/share
0.51
Dividend
-
Dividend %
-
Employees
3.9K
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
-6.51
Forward P/E
-
PEG
1.11
P/S
1.71
P/B
1.27
P/C
10.49
P/FCF
22.49
Quick Ratio
0.47
Current Ratio
1.01
Debt / Equity
0.37
LT Debt / Equity
0.32
-
-
EPS (TTM)
-0.34
EPS next Y
-
EPS next Q
-
EPS this Y
-58.02%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
1.52%
EPS Q/Q
323.08%
-
-
-
-
SMA20
9.76%
SMA50
-15.09%
SMA100
23.57%
Inst Own
0.05%
Inst Trans
0.98%
ROA
-11%
ROE
-19%
ROC
0.01%
Gross Margin
50%
Oper. Margin
3%
Profit Margin
-28%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.53-7.08
52W High
-23.57%
52W Low
+167.5%
RSI
48.34
Rel Volume
0.22
Avg Volume
408.96K
Volume
89.36K
Perf Week
-9.93%
Perf Month
15.05%
Perf Quarter
38.6%
Perf Half Y
15.3%
-
-
-
-
Beta
1.466
-
-
Volatility
0.23%, 0.62%
Prev Close
-0.93%
Price
5.35
Change
11.46%
VRNOF Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 2.57 | 2.65 | 2.74 | |
| Net income per share | 0 | 0 | -0.04 | -0.81 | -0.34 | |
| Operating cash flow per share | 0 | 0 | 0.63 | 0.28 | 0.32 | |
| Free cash flow per share | 0 | 0 | 0.11 | -0.07 | 0.21 | |
| Cash per share | 0 | 0 | 0.34 | 0.26 | 0.51 | |
| Book value per share | 0 | 0 | 5.13 | 4.05 | 3.62 | |
| Tangible book value per share | 0 | 0 | -0.94 | -0.33 | -0.23 | |
| Share holders equity per share | 0 | 0 | 5.13 | 4.05 | 3.62 | |
| Interest debt per share | 0 | 0 | 1.31 | 1.65 | 1.76 | |
| Market cap | 9.09B | 8.87B | 4.61B | 1.03B | 1.54B | |
| Enterprise value | 9.09B | 8.87B | 4.86B | 1.45B | 1.9B | |
| P/E ratio | -150.59K | -33.58K | -378.89 | -3.85 | -13.09 | |
| Price to sales ratio | 0 | 0 | 6.25 | 1.18 | 1.64 | |
| POCF ratio | -171.57K | -49.62K | 25.44 | 10.96 | 14 | |
| PFCF ratio | -171.57K | -49.62K | 146.08 | -41.65 | 20.93 | |
| P/B Ratio | -114.41K | -40.98K | 3.12 | 0.77 | 1.24 | |
| PTB ratio | -114.41K | -40.98K | 3.12 | 0.77 | 1.24 | |
| EV to sales | 0 | 0 | 6.59 | 1.65 | 2.03 | |
| Enterprise value over EBITDA | -156.79K | -37.94K | 22.78 | 10.82 | 6.36 | |
| EV to operating cash flow | -171.57K | -49.62K | 26.84 | 15.35 | 17.35 | |
| EV to free cash flow | -171.57K | -49.62K | 154.13 | -58.32 | 25.94 | |
| Earnings yield | 0 | 0 | 0 | -0.26 | -0.08 | |
| Free cash flow yield | 0 | 0 | 0.01 | -0.02 | 0.05 | |
| Debt to equity | -0.7 | -0.3 | 0.24 | 0.37 | 0.44 | |
| Debt to assets | 22.9 | 4.18 | 0.14 | 0.21 | 0.23 | |
| Net debt to EBITDA | -0.95 | -0.25 | 1.19 | 3.09 | 1.23 | |
| Current ratio | 0.03 | 0.07 | 0.58 | 0.82 | 0.96 | |
| Interest coverage | -10.28 | -15.39 | 4.44 | -0.33 | 1.42 | |
| Income quality | 0.83 | 0.72 | -12.35 | -0.35 | -0.93 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0.24 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0.69 | 0.61 | 0.57 | |
| Capex to operating cash flow | 0 | 0 | -0.83 | -1.26 | -0.33 | |
| Capex to revenue | 0 | 0 | -0.2 | -0.14 | -0.04 | |
| Capex to depreciation | 0 | 0 | -1.55 | -0.79 | -0.24 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0.04 | 0.01 | |
| Graham number | 0 | 0 | 2.21 | 8.6 | 5.28 | |
| ROIC | 2.34 | 1.65 | -0.01 | -0.01 | -0.19 | |
| Return on tangible assets | -24.71 | -16.78 | -0.02 | -0.28 | -0.12 | |
| Graham Net | 0 | 0 | -3.08 | -2.64 | -2.35 | |
| Working capital | -79.43K | -216.5K | -195.88M | -68.37M | -17.99M | |
| Tangible asset value | -79.43K | -216.5K | -269.31M | -108.3M | -77.36M | |
| Net current asset value | -79.43K | -216.5K | -793.01M | -736.23M | -684.47M | |
| Invested capital | -0.7 | -0.3 | 0.24 | 0.37 | 0.44 | |
| Average receivables | 0 | 5.26K | 8.85M | 17.14M | 27.78M | |
| Average payables | 0 | 59.92K | 22.63M | 42.84M | 35.89M | |
| Average inventory | 0 | 0 | 68.82M | 151.08M | 152.61M | |
| Days sales outstanding | 0 | 0 | 8.75 | 6.88 | 15.16 | |
| Days payables outstanding | 0 | 0 | 40.88 | 32.39 | 24.65 | |
| Days of inventory on hand | 0 | 0 | 124.57 | 131.6 | 110.85 | |
| Receivables turnover | 0 | 0 | 41.7 | 53.04 | 24.07 | |
| Payables turnover | 0 | 0 | 8.93 | 11.27 | 14.81 | |
| Inventory turnover | 0 | 0 | 2.93 | 2.77 | 3.29 | |
| ROE | 0.76 | 1.22 | -0.01 | -0.2 | -0.09 | |
| Capex per share | 0 | 0 | -0.52 | -0.36 | -0.11 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.66 | 0.64 | 0.68 | 0.7 | 0.71 | |
| Net income per share | -0.64 | -0.03 | -0.04 | -0.05 | -0.22 | |
| Operating cash flow per share | 0.09 | 0.05 | 0.07 | 0.11 | 0.1 | |
| Free cash flow per share | 0.06 | 0.02 | 0.05 | 0.08 | 0.07 | |
| Cash per share | 0.25 | 0.27 | 0.3 | 0.38 | 0.51 | |
| Book value per share | 3.95 | 3.76 | 3.87 | 3.82 | 3.59 | |
| Tangible book value per share | -0.32 | -0.25 | -0.23 | -0.2 | -0.24 | |
| Share holders equity per share | 3.95 | 3.76 | 3.87 | 3.82 | 3.59 | |
| Interest debt per share | 1.51 | 1.46 | 1.53 | 1.55 | 1.36 | |
| Market cap | 1.06B | 1.04B | 1.01B | 1.56B | 1.54B | |
| Enterprise value | 1.47B | 1.45B | 1.42B | 1.95B | 1.91B | |
| P/E ratio | -1.23 | -28.11 | -19.34 | -21.9 | -5.17 | |
| Price to sales ratio | 4.7 | 4.57 | 4.32 | 6.51 | 6.32 | |
| POCF ratio | 36.53 | 61.59 | 42.32 | 42.67 | 46.56 | |
| PFCF ratio | 54.17 | 125.02 | 63.58 | 58.62 | 66.9 | |
| P/B Ratio | 0.79 | 0.78 | 0.76 | 1.19 | 1.25 | |
| PTB ratio | 0.79 | 0.78 | 0.76 | 1.19 | 1.25 | |
| EV to sales | 6.53 | 6.37 | 6.05 | 8.12 | 7.83 | |
| Enterprise value over EBITDA | -34.92 | 19.74 | 21.19 | 22.44 | 26.47 | |
| EV to operating cash flow | 50.79 | 85.73 | 59.33 | 53.25 | 57.62 | |
| EV to free cash flow | 75.31 | 174.02 | 89.14 | 73.14 | 82.79 | |
| Earnings yield | -0.2 | -0.01 | -0.01 | -0.01 | -0.05 | |
| Free cash flow yield | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | |
| Debt to equity | 0.37 | 0.38 | 0.38 | 0.39 | 0.37 | |
| Debt to assets | 0.21 | 0.21 | 0.22 | 0.22 | 0.19 | |
| Net debt to EBITDA | -9.8 | 5.56 | 6.08 | 4.46 | 5.08 | |
| Current ratio | 0.82 | 0.87 | 0.92 | 1.01 | 0.96 | |
| Interest coverage | -5.2 | 2.12 | 2.17 | 2.66 | 2.17 | |
| Income quality | -0.13 | -1.83 | -1.83 | -2.06 | -0.44 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.61 | 0.6 | 0.6 | 0.59 | 0.57 | |
| Capex to operating cash flow | -0.33 | -0.51 | -0.33 | -0.27 | -0.3 | |
| Capex to revenue | -0.04 | -0.04 | -0.03 | -0.04 | -0.04 | |
| Capex to depreciation | -0.25 | -0.23 | -0.21 | -0.26 | -0.26 | |
| Stock based compensation to revenue | 0.02 | 0 | 0.02 | 0.02 | 0.02 | |
| Graham number | 7.51 | 1.48 | 1.82 | 2.11 | 4.18 | |
| ROIC | -0.04 | -0.01 | -0.01 | -0.01 | 0.06 | |
| Return on tangible assets | -0.23 | -0.01 | -0.01 | -0.02 | -0.07 | |
| Graham Net | -2.57 | -2.38 | -2.41 | -2.36 | -2.38 | |
| Working capital | -68.37M | -47.63M | -29.39M | 2.7M | -17.9M | |
| Tangible asset value | -108.3M | -90.52M | -77.97M | -69.83M | -83.7M | |
| Net current asset value | -736.23M | -716.74M | -701.53M | -686.61M | -698.86M | |
| Invested capital | 0.37 | 0.38 | 0.38 | 0.39 | 0.37 | |
| Average receivables | 15.89M | 17.42M | 23.45M | 31.49M | 36.55M | |
| Average payables | 46.35M | 35.51M | 32.63M | 32.87M | 31.07M | |
| Average inventory | 166.34M | 159.07M | 149.25M | 147.85M | 145.39M | |
| Days sales outstanding | 6.6 | 7.23 | 11.02 | 12.86 | 14.32 | |
| Days payables outstanding | 29.73 | 23.31 | 26.28 | 26.12 | 22 | |
| Days of inventory on hand | 120.79 | 117.28 | 109.65 | 127.02 | 98.96 | |
| Receivables turnover | 13.63 | 12.44 | 8.17 | 7 | 6.29 | |
| Payables turnover | 3.03 | 3.86 | 3.42 | 3.45 | 4.09 | |
| Inventory turnover | 0.75 | 0.77 | 0.82 | 0.71 | 0.91 | |
| ROE | -0.16 | -0.01 | -0.01 | -0.01 | -0.06 | |
| Capex per share | -0.03 | -0.02 | -0.02 | -0.03 | -0.03 |
VRNOF Frequently Asked Questions
What is Verano Holdings Corp. stock symbol ?
Verano Holdings Corp. is a US stock , located in Chicago of Il and trading under the symbol VRNOF
What is Verano Holdings Corp. stock quote today ?
Verano Holdings Corp. stock price is $5.35 today.
Is Verano Holdings Corp. stock public?
Yes, Verano Holdings Corp. is a publicly traded company.
Company Profile
- Volume Average 408.96K
- Market Capitalization 1.74B
- Employee 3.9K
- CEO Mr. George P. Archos
- Headquarters Chicago,IL,US
- IPO Date 2021-02-18
-
Website
https://www.verano.com 
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. It engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. The company offers artisanal cannabis products under the Encore, Avexia, MUV, and Verano brands for medical and adult-use markets. As of May 10, 2022, it operated 96 retail dispensaries, and 13 cultivation and processing facilities. The company is headquartered in Chicago, Illinois.
